Indian studies on genetic polymorphisms and cancer risk

Indian Journal of Cancer

Volumn 49, Issue 1, 2012, Pages 144-162

  Bag, A ^a   Jyala, N S ^a   Bag, N ^b  

^a Government Medical College   (India)

^b SIKKIM UNIVERSITY   (India)

Author keywords

Cancer association; combined genotype; gene environment interaction; Indian population; polymorphisms

Indexed keywords

GROWTH FACTOR; HORMONE RECEPTOR; VITAMIN RECEPTOR;

APOPTOSIS; CANCER CLASSIFICATION; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE; DNA REPAIR; FOLATE METABOLISM; GENE INTERACTION; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; INDIA; NONHUMAN; REVIEW; XENOBIOTIC METABOLISM;

CELL CYCLE PROTEINS; DNA REPAIR ENZYMES; GENES, MHC CLASS II; GENETIC ASSOCIATION STUDIES; HUMANS; INDIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84865229810     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.98941     Document Type: Review

References (153)

1. Marsh S, McLeod HL. Pharmacogenetics and oncology treatment for breast cancer. Expert Opin Pharmacother 2007;8:119-27. (Pubitemid 46206615)
2. Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol 2008;32:945-73.
3. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000;9:3-28. (Pubitemid 30062906)
4. Kumar M, Agarwal SK, Goel SK. Lung cancer risk in North Indian population: Role of genetic polymorphisms and smoking. Mol Cell Biochem 2009;322:73-9.
5. Sreeja L, Vani S, Sreedharan H, Jayprakash M, Choondal DS, Ravindran A. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 2005;50:618-27. (Pubitemid 41768782)
6. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 2008;639:1-10.
7. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. Biomarkers 2003;8:415-28. (Pubitemid 37509174)
8. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir valley and influence of environmental factors. Nutr Cancer 2010;62:734-42.
9. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir valley. J Gastrointest Cancer 2009;40:26-32.
10. Sobti RC, Onsory K, Badran AI, Kaur P, Watanabe M, Krishan A, et al. CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population. DNA Cell Biol 2006;25:287-94. (Pubitemid 43830442)
11. Sobti RC, Gupta L, Thakur H, Seth A, Singh SK, Kaur P. CYP17 gene polymorphism and its association in North Indian prostate cancer patients. Anticancer Res 2009;29:1659-63.
12. Devasena A, Chaubal PC, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: Tobacco Exposure as a risk modulator. Carcinogenesis 2007;28:1455-62. (Pubitemid 47241795)
13. Pandey SN, Jain M, Nigam P, Choudhuri G, Mittal B. Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India. Biomarkers 2006;11:250-61. (Pubitemid 43879071)
14. Majumdar S, Mondal BC, Ghosh M, Dey S, Mukhopadhyay A, Chandra S, et al. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia. Eur J Cancer Prev 2008;17:125-32. (Pubitemid 351301623)
15. Kotnis A, Kannan S, Sarin R, Mulherkar R. Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. Br J Cancer 2008;99:1340-7.
16. Sharma R, Ahuja M, Panda NK, Khullar M. Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians. Oral Dis 2010;16:760-8.
17. Ihsan R, Chattopadhyay I, Phukan R, Mishra AK, Purkayastha J, Sharma J, et al. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India. J Gastroen Hepatol 2010;25:1456-62.
18. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharm 2008;230:247-51.
19. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009;458:1127-30.
20. Krizhanovsky V, Lowe SW. The promises and perils of p53. Nature 2009;460:1085-86.
21. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-100. (Pubitemid 29046852)
22. Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R, et al. Infection of Human Papillomavirus Type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005;128:3999-4007. (Pubitemid 43062663)
23. Gochhait S, Bukhari SI, Bairwa N, Vadhera S, Darvishi K, Raish M, et al. Implication of BRCA2-26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon72 Arg>Pro polymorphism. Breast Cancer Res 2007;9: R71.
24. Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, et al. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol 2002;86:157-62. (Pubitemid 34953498)
25. Sameer AS, Shah ZA, Syeed N, Banday MJ, Bashir SM, Bhat BA. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population. Genet Mol Res 2010;9:651-60.
26. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, et al. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell 2003;3:387-402. (Pubitemid 38340307)
27. Misra C, Majumder M, Bajaj S, Ghosh S, Roy B, Roychoudhury S. Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinog 2009;48:790-800.
28. Satinder K, Chander SR, Pushpinder K, Indu G, Veena J. Cyclin D1 (G870A) polymorphism and risk of cervix cancer: A case control study in North Indian population. Mol Cell Biochem 2008;315:151-7.
29. Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol 2006;42:607-13. (Pubitemid 43947667)
30. Thakur N, Hussain S, Kohaar I, Tabassum R, Nasare V, Tiwari P, et al. Genetic variant of CCND1: Association with HPV-mediated cervical cancer in Indian population. Biomarkers 2009;14:219-25.
31. Han JY, Lee GK, Jang DH, Lee SY, Lee JS. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer. Cancer 2008;113:799-807.
32. Kesarwani P, Mandal RK, Maheshwari R, Mittal RD. Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU Int 2011;107:471-6.
33. Gangwar R, Mandhani A, Mittal RD. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in North Indian population. Ann Surg Oncol 2009;16:2028-34.
34. Drapkin R, Sancar A, Reinberg D. Where transcription meets repair. Cell 1994;77:9-12. (Pubitemid 24184681)
35. Gangwar R, Ahirwar D, Mandhani A, Mittal RD. Influence of XPD and APE1 DNA Repair Gene Polymorphism on Bladder Cancer Susceptibility in North India. Urology 2009;73:675-80.
36. Shekari M, Sobti RC, Tamandani DM, Malekzadeh K, Kaur P, Suri V. Association of genetic polymorphism of the DNA base excision repair gene (APE-1 Asp/148 Glu) and HPV type (16/18) with the risk of cervix cancer in North Indian population. Cancer Biomark 2008;4:63-71. (Pubitemid 351712266)
37. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: An exploratory study. Clin Immunol 2008;128:199-204.
38. Kumar S, Kumar A, Dixit VK. Evidences showing association of interleukin-1B polymorphisms with increased risk of gastric cancer in an Indian population. Biochem Biophys Res Commun 2009;387:456-60.
39. Vishnoi M, Pandey SN, Choudhuri G, Mittal B. IL-1gene polymorphisms and genetic susceptibility of gallbladder cancer in a North Indian population. Cancer Genet Cytogenet 2008;186:63-8.
40. Kesarwani P, Ahirwar DK, Mandhani A, Mittal RD. Association between-174 G/C promoter polymorphism of the Interleukin-6gene and progression of prostate cancer in North Indian population. DNA Cell Biol 2008;27:505-10.
41. Vishnoi M, Pandey SN, Choudhury G, Kumar A, Modi DR, Mittal B. Do TNFA-308 G/A and IL6-174 G/C gene polymorphisms modulate risk of gallbladder cancer in the North Indian population? Asian Pac J Cancer Prev 2007;8:567-72.
42. Gangwar R, Mittal B, Mittal RD. Association of interleukin-6-174G>C promoter polymorphism with risk of cervical cancer. Int J Biol Markers 2009;24:11-6.
43. Kesarwani P, Ahirwar DK, Mandhani A, Singh AN, Dalela D, Srivastava AN, et al. IL-10-1082 G>A: A risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort. World J Urol 2009;27:389-96.
44. Ahirwar D, Mandhani A, Mittal RD. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer. Arch Med Res 2009;40:97-102.
45. Pooja S, Francis A, Bid HK, Kumar S, Rajender S, Ramalingam K, et al. Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India. Breast Cancer Res Treat 2011;126:739-47.
46. Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, et al. Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 2009;114:347-55.
47. Singh H, Jain M, Sachan R, Mittal B. Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer 2009;19:1190-4.
48. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, et al. TNF alpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 2007;29:249-56. (Pubitemid 46855705)
49. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma. Mutat Res 2009;663:52-9.
50. Srivastava A, Pandey SN, Choudhuri G, Mittal B. CCR5 Delta32 polymorphism: Associated with gallbladder cancer susceptibility. Scand J Immunol 2008;67:516-22. (Pubitemid 351519396)
51. Srivastava A, Mittal B. Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in North Indian population. Scand J Immunol 2009;70:614-20.
52. Pandey S, Mittal RD, Srivastava M, Srivastava K, Singh S, Srivastava S, et al. Impact of Toll-like receptors TLR 2 (-196 to-174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women. Gynecol Oncol 2009;114:501-5.
53. Kordi Tamandani MK, Sobti RC, Shekari M, Mukesh M, Suri V. Expression and polymorphism of IFN-γ gene in patients with cervical cancer. Exp Oncol 2008;30:224-9.
54. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: Modulation of risk in esophageal cancer. Oncol Res 2008;17:167-74.
55. Surekha D, Vishnupriya S, Nageswara Rao D, Sailaja K, Raghunadharao D. PvuII polymorphism of estrogen receptor-α gene in breast cancer. Ind J Human Genet 2007;13:97-101. (Pubitemid 351252642)
56. Surekha D, Sailaja K, Nageswara Rao D, Raghunadharao D, Vishnupriya S. Oestrogen receptor beta (ERβ) polymorphism and its influence on breast cancer risk. J Genet 2009;88:261-6.
57. Govindan S, Ahmad SN, Vedicherla B, Kodati V, Jahan P, Rao KP, et al. Association of progesterone receptor gene polymorphism (PROGINS) with endometriosis, uterine fibroids and breast cancer. Cancer Biomarkers 2007;3:73-8. (Pubitemid 47103808)
58. Onsory K, Sobti RC, Badran AI, Watanabe M, Shiraishi T, Krishan A, et al. Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population. Mol Cell Biochem 2008;314:25-35.
59. Mishra D, Thangaraj K, Mandhani A, Kumar A, Mittal R. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Clin Genet 2005;68:55-60. (Pubitemid 40867539)
60. Mittal RD, Srivastava DS, Mishra DK. Is urokinase gene 3'-UTR polymorphism associated with prostate cancer? Cancer Biomarkers 2005;1:287-92.
61. Singh H, Jain M, Mittal B. MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer. Gynecol Oncol 2008;110:71-5.
62. Srivastava P, Gangwar R, Kapoor R, Mittal RD. Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population. Dis Markers 2010;29:37-46.
63. Mittal RD, Manchanda PK, Bhat S, Bid HK. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population. BJU Int 2007;99:933-7. (Pubitemid 46439554)
64. Mishra DK, Bid HK, Srivastava DS, Mandhani A, Mittal RD. Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India. Urol Int 2005;74:315-8. (Pubitemid 40864154)
65. Chandy S, Adiga MN, Ramachandra N, Krishnamoorthy S, Savithri GR, Krishnamoorthy L, et al. Association of methylenetetrahydrofolate reductase gene polymorphisms and colorectal cancer in India. Indian J Med Res 2010;131:659-64.
66. Wang J, Gajalakshmi V, Jiang J, Kuriki K, Suzuki S, Nagaya T, et al. Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: A case-control study in an Indian population. Int J Cancer 2006;118:991-7. (Pubitemid 43157676)
67. Shekari M, Sobti RC, Kordi Tamandani DM, Suri V. Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 2008;278:517-24.
68. Sam SS, Thomas V, Sivagnanam K, Reddy KS, Surianarayanan G, Chandrasekaran A, et al. ABCB1 genetic polymorphism and risk of upper aerodigestive tract cancers among smokers, tobacco chewers and alcoholics in an Indian population. Pharmacogenet Genomics 2007;17:861-6. (Pubitemid 47462299)
69. Srivastava A, Tulsyan S, Pandey SN, Choudhuri G, Mittal B. Single nucleotide polymorphism in the ABCG8 transporter gene is associated with gallbladder cancer susceptibility. Liver Int 2009;29:831-7.
70. Vineis P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 2002;181-2:457-62. (Pubitemid 36015737)
71. Kotnis A, Sarin R, Mulherkar R. Genotype, phenotype and cancer: Role of low penetrance genes and environment in tumour susceptibility. J Biosci 2005;30:93-102. (Pubitemid 40571504)
72. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-7. (Pubitemid 26301653)
73. Katsnelson A. Genetics tells tall tales. Nature 2010;465:998.
74. Bag A, Bag A. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: A review. Cancer Epidemiol Biomarkers Prev 2008;17:3298-305.
75. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, et al. Occupation and cancer-follow-up of 15 million people in five Nordic countries. Acta Oncol 2009;48:646-790.
76. Matsuo K, Wakai K, Hirose K, Ito H, Saito T, Tajima K. Alcohol dehydrogenase 2 His47Arg polymorphism influences drinking habit independently of aldehyde dehydrogenase 2 Glu487Lys polymorphism: Analysis of 2,299 Japanese subjects. Cancer Epidemiol Biomarkers Prev 2006;15:1009-13. (Pubitemid 43823531)
77. Lee HC, Lee HS, Jung SH, Yi SY, Jung HK, Yoon JH, et al. Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. J Korean Med Sci 2001;16:745-50. (Pubitemid 33741062)
78. Otsuka M, Harada N, Itabashi T, Ohmori S. Blood and urinary levels of ethanol, acetaldehyde, and C4 compounds such as diacetyl, acetoin, and 2,3-butanediol in normal male students after ethanol ingestion. Alcohol 1999;17:119-24. (Pubitemid 29096199)
79. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, et al. Validating genetic risk associations for ovarian cancer through the international ovarian cancer association consortium. Br J Cancer 2009;100:412-20.
80. Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, et al. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 2008;638:185-94.
81. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 2005;48:339-44. (Pubitemid 40957115)
82. Soya SS, Vinod T, Reddy KS, Gopalakrishnan S, Adithan C. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population. Eur J Cancer 2007;43:2698-706. (Pubitemid 350151835)
83. Kiran M, Saxena R, Chawla YK, Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem 2009;327:7-13.
84. Mittal RD, Srivastava DS, Mandhani A, Mittal B. Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India. Asian Pac J Cancer Prev 2005;6:6-9.
85. Malik MA, Zargar SA, Mittal B. Lack of influence of DNA repair gene OGG1 codon 326 polymorphisms of gastric cancer risk in the Kashmir valley. Asian Pac J Cancer Prev 2010;11:165-8.
86. Shah PP, Singh AP, Singh M, Mathur N, Mishra BN, Pant MC, et al. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. Mutat Res 2008;643:4-10.
87. Sharma R, Ahuja M, Panda NK, Khullar M. Combined effect of smoking and polymorphisms in tobacco carcinogen-metabolizing enzymes CYP1A1 and GSTM1 on the head and neck cancer risk in North Indians. DNA Cell Biol 2010;29:441-8.
88. Ruwali M, Pant MC, Shah PP, Mishra BN, Parmar D. Polymorphism in cytochrome P450 2A6 and glutathione S-transferase P1 modifies head and neck cancer risk and treatment outcome. Mutat Res 2009;669:36-41.
89. Ruwali M, Khan AJ, Shah PP, Singh AP, Pant MC, Parmar D. Cytochrome P450 2E1 and head and neck cancer: Interaction with genetic and environmental risk factors. Environ Mol Mutagen 2009;50:473-82.
90. Yadav SS, Ruwali M, Shah PP, Mathur N, Singh RL, Pant MC, et al. Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response. Mutat Res 2008;644:31-7.
91. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 2001;37:593-8. (Pubitemid 32889622)
92. Chatterjee S, Chakrabarti S, Sengupta B, Poddar S, Biswas D, Sengupta S, et al. Prevalence of CYP1A1 and GST polymorphisms in the population of northeastern India and susceptibility of oral cancer. Oncol Res 2009;17:397-403.
93. Sam SS, Thomas V, Reddy SK, Surianarayanan G, Chandrasekaran A. CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. Head Neck 2008;30:1566-74.
94. Jain M, Kumar S, Ghosal UC, Mittal B. CYP1A1 Msp1 T/C polymorphism in esophageal cancer: No association and risk modulation. Oncol Res 2007;16:437-43.
95. Pandey SN, Choudhuri G, Mittal B. Association of CYP1A1 Msp1 polymorphism with tobacco-related risk of gallbladder cancer in a North Indian population. Eur J Cancer Prev 2008;17:77-81. (Pubitemid 351301617)
96. Surekha D, Sailaja K, Nageswara Rao D, Padma T, Raghunadharao D, Vishnupriya S. Association of CYP1A1FNx012 Polymorphisms with breast cancer risk: A case control study. Indian J Med Sci 2009;63:13-20.
97. Singh N, Mitra AK, Garg VK, Agarwal A, Sharma M, Chaturvedi R, et al. Association of CYP1A1 polymorphisms with breast cancer in North Indian women. Oncol Res 2007;16:587-97. (Pubitemid 351344781)
98. Vijayalakshmi K, Vettriselvi V, Krishnan M, Shroff S, Jayanth VR, Paul SF. Cytochrome p4501A1 gene variants as susceptibility marker for prostate cancer. Cancer Biomark 2005;1:251-8.
99. Joseph T, Kusumakumary P, Chacko P, Abraham A, Radhakrishna PM. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children. Pediatr Blood Cancer 2004;43:560-7. (Pubitemid 39313955)
100. Bajpai P, Tripathy AK, Agrawal D. Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients. Mol Cell Biochem 2009;336:49-54.
101. Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, et al. Glutathione S-transferase M1, T1 and P1 polymorphisms: Susceptibility and outcome in lung cancer patients. J Exp Ther Oncol 2008;7:73-85. (Pubitemid 351521217)
102. Sabitha K, Reddy MV, Jamil K. GST genotypes in head and neck cancer patients and its clinical implications. Afr J Biotechnol 2008;7:3853-9.
103. Buch SC, Notani PN, Bhisey RA. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 2002;23:803-7. (Pubitemid 34567519)
104. Sharma A, Mishra A, Das BC, Sardana S, Sharma JK. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer. Neoplasma 2006;53:309-15. (Pubitemid 44105936)
105. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B. Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol Biomarkers Prev 2007;16:178-81. (Pubitemid 46174284)
106. Tripathi S, Ghoshal U, Ghoshal UC, Mittal B, Krishnani N, Chourasia D, et al. Gastric carcinogenesis: Possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroentero 2008;43:431-9. (Pubitemid 351450979)
107. Asim M, Khan LA, Husain SA, Husain S, Sarma MP, Ahmad I, et al. Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Disease Markers 2010;28:369-76.
108. Kiran M, Chawla YK, Kaur J. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India. DNA Cell Biol 2008;27:687-94. (Pubitemid 352773920)
109. Samson M, Swaminathan R, Rama R, Sridevi V, Nancy KN, Rajkumar T. Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and p53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer: A case control study from South India. Asian Pac J Cancer Prev 2007;8:253-7.
110. Saxena A, Dhillon VS, Raish M, Asim M, Rehman S, Shukla NK, et al. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res Treat 2009;115:537-43.
111. Syamala VS, Sreeja L, Syamala V, Raveendran PB, Balakrishnan R, Kuttan R, et al. Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam Cancer 2008;7:213-20.
112. Singh H, Sachan R, Devi S, Pandey SN, Mittal B. Association of GSTM1, GSTT1, and GSTM3 gene polymorphisms and susceptibility to cervical cancer in a North Indian population. Am J Obstet Gynecol 2008;198:303.e1-303.e6.
113. Mittal RD, Srivastava DS, Mandhani A, Kumar A, Mittal B. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: A study from North India. Indian J Cancer 2004;41:115-9. (Pubitemid 39456946)
114. Srivastava DS, Mandhani A, Mittal B, Mittal RD. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int 2005;95:170-3. (Pubitemid 350020890)
115. Kesarwani P, Singh R, Mittal RD. Association of GSTM3 intron 6 variant with cigarette smoking, tobacco chewing and alcohol as modifier factors for prostate cancer risk. Arch Toxicol 2009;83:351-6.
116. Suneetha KJ, Nancy KN, Rajalekshmy KR, Sagar TG, Rajkumar T. Role of GSTM1 (Present/Null) and GSTP1 (Ile105Val) polymorphisms in susceptibility to acute lymphoblastic leukemia among the South Indian population. Asian Pac J Cancer Prev 2008;9:733-6.
117. Bajpai P, Agrawal D, Tripathy AK. Genetic polymorphism of Glutathione S-Transferase M1 and T1 and risk to chronic myeloid leukemia. Proc Amer Assoc Cancer Res 2006;47: Epidemiology 12: Susceptibility Genes and Diverse Pathways to Malignancy Abstract #4588.
118. Srivastava DS, Kumar A, Mittal B, Mittal RD. Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: A study from North India. Arch Toxicol 2004;78:430-4. (Pubitemid 39222679)
119. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B. Association of genetic polymorphisms of N-Acetyltransferase 2 and susceptibility to esophageal cancer in North Indian population. Cancer Invest 2007;25:340-6. (Pubitemid 47185079)
120. Malik MA, Upadhyay R, Modi DR, Zargar SA, Mittal B. Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley. Arch Med Res 2009;40:416-23.
121. Srivastava DS, Mittal RD. Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: A pilot study in North Indian population. BMC Urol 2005;5:12.
122. Pachouri SS, Sobti RC, Kaur P, Singh J, Gupta SK. Impact of polymorphism in sulfotransferase gene on the risk of lung cancer. Cancer Genet Cytogenet 2006;171:39-43. (Pubitemid 44635751)
123. Chacko P, Rajan B, Mathew BS, Joseph T, Pillai MR. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer. Breast Cancer 2004;11:380-8.
124. Sobti RC, Kaur P, Kaur S, Singh J, Janmeja AK, Jindal SK, et al. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population. Cancer Genet Cytogenet 2006;170:108-14. (Pubitemid 44442461)
125. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B. Role of BCL2 (ala43 th r), CCND1 (G870A) and FAS(A-670G) polymorphisms in modulating the risk of developing esophageal cancer. Cancer Detect Prev 2007;31:225-32. (Pubitemid 47248152)
126. Jiang J, Wang J, Suzuki S, Gajalakshmi V, Kuriki K, Zhao Y, et al. Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population. J Cancer Res Clin Oncol 2006;132:193-9. (Pubitemid 43015780)
127. Kordi Tamandani DM, Sobti RC, Shekari M. Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population. Clin Exp Obstet Gynecol 2008;35:183-6.
128. Pal R, Gochhait S, Chattopadhyay S, Gupta P, Prakash N, Agarwal G, et al. Functional implication of TRAIL-716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor. Breast Cancer Res Treat 2011;126:333-43.
129. Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran P, Vijayalekshmi R, et al. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 2008;134:645-52. (Pubitemid 351502740)
130. Pachouri SS, Sobti RC, Kaur P, Singh J. Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population. DNA Cell Biol 2007;26:186-91. (Pubitemid 46557387)
131. Sobti RC, Singh J, Kaur P, Pachouri SS, Siddiqui EA, Bindra HS. XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population. Cancer Genet Cytogenet 2007;175:91-7. (Pubitemid 46855927)
132. Srivastava A, Srivastava K, Pandey SN, Choudhuri G, Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: Association with gallbladder cancer in North Indian population. Ann Surg Oncol 2009;16:1695-703.
133. Mitra AK, Singh N, Singh A, Garg VK, Agarwal A, Sharma M, et al. Association of polymorphisms in base excision repair genes with the risk of breast cancer: A case-control study in North Indian women. Oncol Res 2008;17:127-35. (Pubitemid 352006266)
134. Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 2005;89:15-21. (Pubitemid 40228443)
135. Mandal RK, Gangwar R, Mandhani A, Mittal RD. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: A study from North India. DNA Cell Biol 2010;29:183-90.
136. Gangwar R, Mittal B, Srivastava S, Singh H, Mittal RD. Genetic variants of DNA repair gene XPC modulating susceptibility to cervical cancer in North India. Oncol Res 2010;18:329-35.
137. Mitra AK, Singh N, Garg VK, Chaturvedi R, Sharma M, Rath SK. Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the North Indian population. J Exp Clin Cancer Res 2009;28:104.
138. Srivastava K, Srivastava A, Mittal B. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Cancer 2010;116:3160-9.
139. Upadhyay R, Malik MA, Zargar SA, Mittal B. OGG1 Ser326Cys polymorphism and susceptibility to esophageal cancer in low and high at-risk populations of northern India. J Gastrointest Cancer 2010;41:110-5.
140. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B. Potential influence of interleukin-1 haplotype IL-1 beta-511FNx01T-IL-1RNFNx011 in conferring low risk to middle third location of esophageal cancer: A case-control study. Hum Immunol 2008;69:179-86.
141. Konwar R, Chaudhary P, Kumar S, Mishra D, Chattopadhyay N, Bid HK. Breast cancer risk associated with polymorphisms of IL-1RN and IL-4 gene in Indian women. Oncol Res 2009;17:367-72.
142. Singh H, Sachan R, Goel H, Mittal B. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer. BJOG 2008;115:633-8. (Pubitemid 351357571)
143. Bid HK, Manchanda PK, Mittal RD. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India. Urology 2006;67:1099-104. (Pubitemid 43956428)
144. Gupta R, Sharma SC, Das SN. Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol 2008;44:455-63.
145. Srivastava K, Srivastava A, Pandey SN, Kumar A, Mittal B. Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. J Gastroenterol 2009;44:774-80.
146. Pandey S, Mittal RD, Srivastava M, Srivastava K, Mittal B. Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population. Int J Gynecol Cancer 2010;20:625-30.
147. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1-509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 2008;69:360-7.
148. Saha A, Gupta V, Bairwa NK, Malhotra D, Bamezai R. Transforming growth
149. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in North Indians. Cancer Detect Prev 2009;32:386-94.
150. Jain M, Kumar S, Ghoshal UC, Mittal B. Association of ECRG2 TCA short tandem repeat polymorphism with the risk of oesophageal cancer in a North Indian population. Clin Exp Med 2008;8:73-8. (Pubitemid 351999725)
151. Srivastava K, Srivastava A, Mittal B. Angiotensin I-converting enzyme insertion/deletion polymorphism and increased risk of gall bladder cancer in women. DNA Cell Biol 2010;29:417-22.
152. Surekha D, Vishnupriya S, Sailaja K, Nageswara Rao D, Raghunadharao D. Influence of Apolipoprotein E gene polymorphism on the risk for breast cancer. Int J Hum Genet 2008;8:277-82.
153. Jiang J, Gajalakshmi V, Wang J, Kuriki K, Suzuki S, Nakamura S, et al. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population. Cancer Sci 2005;96: 507-12. (Pubitemid 41387303)